CASP3 and cancer: In HCerEpC and Ect1/E6E7 epithelial cells, treatment with SKI-V however failed to significantly increase the caspase-3 activity (Figure 2F) and TUNEL-positive nuclei ratio (Figure 2G), again showing the cancer cell specific effect.